diflucortolone and Dermatitis

diflucortolone has been researched along with Dermatitis* in 4 studies

Trials

1 trial(s) available for diflucortolone and Dermatitis

Article	Year
[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases]. Zeitschrift fur Hautkrankheiten, 1985, Feb-01, Volume: 60, Issue:3 We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially treated with 0.1% difluocortolone valerate. During the maintenance therapy carried out over a period of 3 to 4 weeks, we tested the efficacy of Kamillosan cream vs. 0.25% hydrocortisone, 0.75% fluocortin butyl ester, and 5% bufexamac in a bilateral comparative study. For the indications tested Kamillosan cream showed more or less equieffective therapeutic results as compared to 0.25% hydrocortisone. It is superior, however, to the non-steroidal anti-inflammatory agent 5% bufexamac as well as to 0.75% fluocortin butyl ester, a further glucocorticoid. With regard to neurodermitis, Kamillosan cream not only shows the same therapeutic effect as 0.25% hydrocortisone but is even of marked superiority towards other reference products. Topics: Adolescent; Adult; Aged; Bufexamac; Chamomile; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact; Dermatitis, Seborrheic; Diflucortolone; Female; Fluocortolone; Humans; Hydrocortisone; Hydroxamic Acids; Male; Middle Aged; Neurodermatitis; Oils, Volatile; Ointments; Plant Extracts; Plants, Medicinal	1985

Article

Year

[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].

Zeitschrift fur Hautkrankheiten, 1985, Feb-01, Volume: 60, Issue:3

We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially treated with 0.1% difluocortolone valerate. During the maintenance therapy carried out over a period of 3 to 4 weeks, we tested the efficacy of Kamillosan cream vs. 0.25% hydrocortisone, 0.75% fluocortin butyl ester, and 5% bufexamac in a bilateral comparative study. For the indications tested Kamillosan cream showed more or less equieffective therapeutic results as compared to 0.25% hydrocortisone. It is superior, however, to the non-steroidal anti-inflammatory agent 5% bufexamac as well as to 0.75% fluocortin butyl ester, a further glucocorticoid. With regard to neurodermitis, Kamillosan cream not only shows the same therapeutic effect as 0.25% hydrocortisone but is even of marked superiority towards other reference products.

Topics: Adolescent; Adult; Aged; Bufexamac; Chamomile; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact; Dermatitis, Seborrheic; Diflucortolone; Female; Fluocortolone; Humans; Hydrocortisone; Hydroxamic Acids; Male; Middle Aged; Neurodermatitis; Oils, Volatile; Ointments; Plant Extracts; Plants, Medicinal

1985

Other Studies

3 other study(ies) available for diflucortolone and Dermatitis

Article	Year
Glaucoma secondary to topical use of steroid cream. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1999, Volume: 34, Issue:4 Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Dermatitis; Diflucortolone; Eczema; Eyelid Diseases; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Ointments; Scotoma; Visual Fields	1999
[Clinical trial of diflucortolone. Preliminary report]. Medicina cutanea ibero-latino-americana, 1981, Volume: 9, Issue:3 Diflucortolone valerianate, a new fluorinated corticosteroid for tropical use, was applied in 52 patients suffering of diverse inflammatory dermatosis. The maximum observation time was 3 weeks. The results were, very good in 63.46%; good in 28.84%; regular in 1.92 %, and bad in 5.76%. In 73.7% of the cases good results were obtained in less than 2 weeks. The cream was cosmetically well accepted and there were no observed side effects. Topics: Adolescent; Adult; Child; Child, Preschool; Dermatitis; Diflucortolone; Drug Evaluation; Fluocortolone; Humans; Infant; Middle Aged; Ointments	1981
[Treatments of different dermatoses with diflucortolonvalerat 0,1% (nerisona). Report on multicentric tests in Switzerland (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Aug-29, Volume: 67, Issue:35 Topics: Dermatitis; Diflucortolone; Drug Evaluation; Eczema; Fluocortolone; Humans; Neurodermatitis; Pregnadienediols; Psoriasis	1978